Cytokine pattern is solely influenced by priming vaccine but immunity and disease by both priming and boosting vaccines in mice challenged with respiratory syncytial virus

Virus Research

Volumn 99, Issue 1, 2004, Pages 81-87

  Tang, Yi Wei ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

IFN ; IL 4; Original antigenic sin; Respiratory syncytial virus; Vaccine

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INACTIVATED VACCINE; INTERLEUKIN 4; LIVE VACCINE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; BIOSYNTHESIS; BLOOD; CELL ACTIVITY; CELLULAR IMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOLOGY; LUNG; LUNG PARENCHYMA; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SERODIAGNOSIS; VACCINATION; VIRUS INFECTION; VIRUS REPLICATION; WEIGHT REDUCTION;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 0347480210     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2003.10.009     Document Type: Conference Paper

References (30)

1. Aung S., Tang Y.W., Graham B.S. Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo. J. Virol. 73:1999;8944-8949.
2. Auwaerter P.G., Rota P.A., Elkins W.R., Adams R.J., DeLozier T., Shi Y., Bellini W.J., Murphy B.R., Griffin D.E. Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J. Infect. Dis. 180:1999;950-958.
3. Berry J.D., Peeling R.W., Brunham R.C. Analysis of the original antigenic sin antibody response to the major outer membrane protein of Chlamydia trachomatis. J. Infect. Dis. 179:1999;180-186.
4. Boyce T.G., Gruber W.C., Coleman-Dockery S.D., Sannella E.C., Reed G.W., Wolff M., Wright P.F. Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children. Vaccine. 18:1999;82-88.
5. Brandenburg A.H., Kleinjan A., van Het Land B., Moll H.A., Timmerman H.H., de Swart R.L., Neijens H.J., Fokkens W., Osterhaus A.D. Type I-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity. J. Med. Virol. 62:2000;267-277.
6. Davenport F., Hennessy A., Francis T. Epidemiological and Immunological significance of age distribution of antibody variants of influenza virus. J. Exp. Med. 98:1953;641-656.
7. Deng X., Li H., Tang Y.W. Cytokine expression in respiratory syncytial virus-infected mice as measured by quantitative reverse-transcriptase PCR. J. Virol. Methods. 107:2003;141-146.
8. Fazekas de St Groth S., Webster R.G. Disquisitions of Original Antigenic Sin. Part I. Evidence in man. J. Exp. Med. 124:1966;331-345.
9. Fischer J.E., Johnson J.E., Kuli-Zade R.K., Johnson T.R., Aung S., Parker R.A., Graham B.S. Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus. J. Virol. 71:1997;8672-8677.
10. Friedewald W.T., Forsyth B.R., Smith C.B., Gharpure M.A., Chanock R.M. Low-temperature-grown RS virus in adult volunteers. JAMA. 203:1968;690-694.
11. Fulginiti V.A., Eller J.J., Downie A.W., Kempe C.H. Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. JAMA. 202:1967;1075-1080.
12. Galli G., Annunziato F., Cosmi L., Manetti R., Maggi E., Romagnani S. Th1 and th2 responses, HIV-1 coreceptors, and HIV-1 infection. J. Biol. Regul. Homeos. Agents. 15:2001;308-313.
13. Garofalo R.P., Patti J., Hintz K.A., Hill V., Ogra P.L., Welliver R.C. Macrophage inflammatory protein-1alpha (not T helper type II cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J. Infect. Dis. 184:2001;393-399.
14. Graham B.S., Henderson G.S., Tang Y.W., Lu X., Neuzil K.M., Colley D.G. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 151:1993;2032-2040.
15. Graham B.S., Perkins M.D., Wright P.F., Karzon D.T. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 26:1988;153-162.
16. Hall C.B. Respiratory syncytial virus and parainfluenza virus. N. Engl. J. Med. 344:2001;1917-1928.
17. Kapikian A.Z., Mitchell R.H., Chanock R.M., Shvedoff R.A., Stewart C.E. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:1969;405-421.
18. ΔΔCt method. Methods. 25:2001;402-408.
19. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:1986;2348-2357.
20. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 17:1996;138-146.
21. Polack F.P., Teng M.N., Collins P.L., Prince G.A., Exner M., Regele H., Lirman D.D., Rabold R., Hoffman S.J., Karp C.L., Kleeberger S.R., Wills-Karp M., Karron R.A. A role for immune complexes in enhanced respiratory syncytial virus disease. J. Exp. Med. 196:2002;859-865.
22. Renzi P.M., Turgeon J.P., Yang J.P., Drblik S.P., Marcotte J.E., Pedneault L., Spier S. Cellular immunity is activated and a TH-2 response is associated with early wheezing in infants after bronchiolitis. J. Pediatr. 130:1997;584-593.
23. Romagnani S., Del Prete G., Manetti R., Ravina A., Annunziato F., De Carli M., Mazzetti M., Piccinni M.P., D'Elios M.M., Parronchi P. Role of TH1/ TH2 cytokines in HIV infection. Immunol. Rev. 140:1994;73-92.
24. Roman M., Calhoun W.J., Hinton K.L., Avendano L.F., Simon V., Escobar A.M., Gaggero A., Diaz P.V. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am. J. Resp. Crit. Care Med. 156:1997;190-195.
25. Scott P., Natovitz P., Coffman R.L., Pearce E., Sher A. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168:1988;1675-1684.
26. Scott T.F., Bonanno D.E. Reactions to live-measles-virus vaccine in children previously inoculated with killed-virus vaccine. N. Engl. J. Med. 277:1967;248-250.
27. Tang Y.W., Graham B.S. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J. Clin. Invest. 94:1994;1953-1958.
28. Tang Y.W., Graham B.S. T cell source of type 1 cytokine determines illness patterns in respiratory syncytial virus-infected mice. J. Clin. Invest. 99:1997;2183-2191.
29. Tsuchiya H., Furukawa M., Matsui M., Katsuki K., Inouye S. 'Original antigenic sin' phenomenon in neutralizing antibody responses in children with enterovirus meningitis. J. Clin. Virol. 19:2000;205-207.
30. Wright P.F., Karron R.A., Belshe R.B., Thompson J., Crowe J.E. Jr., Boyce T.G., Halburnt L.L., Reed G.W., Whitehead S.S., Anderson E.L., Wittek A.E., Casey R., Eichelberger M., Thumar B., Randolph V.B., Udem S.A., Chanock R.M., Murphy B.R. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J. Infect. Dis. 182:2000;1331-1342.